Resources
Explore our media section to discover insightful videos, informative podcasts, and engaging articles showcasing the innovative applications and advancements in cell testing technology.
Primary cells and in vivo immunomodulation using LentiFlash®, a chimeric RNA delivery technology designed for clinical applications
All-in-one delivery of gene-editing system into primary cells and in vivo using LentiFlash® (FlashRNA®), a new tool fo knock-in & knock-out applications
FAQ
Explore our media section to discover insightful videos, informative podcasts, and engaging articles showcasing the innovative applications and advancements in cell testing technology.
How do Flash BioSolutions lentiviral vectors differ to those from other providers?
Flash BioSolutions has developed a proprietary purification & concentration process for lentiviral vectors production. Purification levels are tailored to your application.
Flash BioSolutions generates high titer and highly pure lentiviral particles that guarantee cell viability and phenotype. Our technical experts are dedicated to the success of your project, from cassette design to transduction protocols.
What are the differences between AAV and Lentiviral vectors?
Each method has both advantages and drawbacks for specific applications, depending on its technical characteristics. For example, the use of AAVs for the transfer of genetic material is limited by the length of the sequence of interest and by the pseudotype; non-viral methods can be problematic for the study of gene expression in primary cells because of cell toxicity and/or lower efficiency.
CONTACT US
We invite you to reach out to us for any inquiries regarding our services, technical support, or potential collaborations.
Please complete the following form, and a member of our team will respond promptly.
+33(0) 5 61 28 70 75